subscribe
 

OGT develops optimised rare disease sequencing and analysis service

Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare...

New international genome research centre to open in Denmark

BGI Europe, a subsidiary of the leading Chinese genomic organisation previously known as Beijing Genomics Institute, will open its first...

Vela and Anagnostics enter strategic partnership

Viennese Vela Laboratories are among the leading companies offering efficacy and release testing for biopharmaceuticals under GMP...

Bio economy grows at Reims Management School

Reims Management School has launched a new chair dedicated to agri-bio-industrial research, confirming its contribution to the development of the bio-based economy, one of Europe’s most important growth markets.

Scientists reveal how cholera bacterium gains a foothold in the gut

A team of biologists at the University of York has made an important advance in our understanding of the way cholera attacks the body.

Thousands of dogs and other animals spared cruel chemical tests in Europe

Humane Society International/Europe is celebrating a change in European law on biocides (non-food pesticides) that will save tens of thousands of dogs, rabbits and rodents from painful and lethal chemical poisoning tests - the largest...

Highly specific Lp(a) assay from Randox available for chemistry analysers

The Randox liquid ready to use Lipoprotein (a) assay provides a highly sensitive and specific method for the detection of Lp(a) in human serum and plasma.

Trophos launches first study of olesoxime in Multiple Sclerosis patients

Trophos SA announces the initiation of a phase 1b study of olesoxime in multiple sclerosis (MS) patients as a complementary therapy to their treatment with interferon beta.

PPPs standing behind the growth of pharma R&D

In the past years, many blockbuster drugs lost their patents. To avoid the resulting decline in sales, pharma companies had to start looking for new wonder drugs. Considering the main factors such as time horizon and financial resources,...

Almac’s clinical trial workshop series to return in 2013

The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.”

Queen's scientist named Innovator of the Year

A Queen's University scientist has won two national awards for his research on microneedles which deliver drugs without causing pain or bleeding.

Prokarium receives grant to develop next generation vaccines

A consortium comprising vaccine developer Prokarium Ltd and the University of Birmingham’s Institute of Microbiology and Infection has received an award for 'advancing the industrial application of synthetic biology'.

Protomold - A shot in the arm for next generation diagnostics

Bacterial endotoxin contamination is an issue all medical device manufacturers need to be aware of. Clinical implants, and all vaccines and...

Promising pre-clinical data in Cystic Fibrosis for ProtAffin AG’s PA401 to be presented at ATS, Philadelphia, 17-22 May 2013

ProtAffin AG has announced that a collaboration with a leading European centre for the study of cystic fibrosis has generated promising pre-clinical results for the company’s lead anti-inflammatory product, PA401.

Almac to deliver insight into Supply Chain Management at Clinical Trial Supply Europe Event

Almac, leading provider of contract services to the global Pharmaceutical and Biotech industries, will play a key role in delivering industry insight on the topic of Supply Chain Management at this year’s 14th Annual CTS Europe event,...

Nano-machines for 'Bionic Proteins'

Physicists of the University of Vienna together with researchers from the University of Natural Resources and Life Sciences Vienna developed...

Prosthetics study to improve mobility of amputees

Research by the University of Salford, University of Manchester and prosthetics company Blatchford’s Endolite Technology Centre will help to enhance the mobility of people with above-knee amputations by improving the energy efficiency of...

Patent changes - who will lose and who will gain?

Is the European unitary patent protection system equally harmful for SME of whole Central Europe? Find out at the 12th edition of the biggest CE innovative biobusiness affairs – BioForum, held in Budapest from 22nd to 23rd of May 2013.

Pharmapack Europe 2013

On 13 & 14 February 2013, the healthcare industry’s major players will meet for the occasion of the 12th edition of Pharmapack Europe in...

Almac launches US commercial packaging operations with successful FDA inspection

Almac has announced the successful inspection of its new US Commercial Packaging operations located in Audubon, PA by the Food and Drug Administration (FDA).

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe